Human Papillomavirus Vaccine Acceptability Among Healthcare Workers, Parents, and Adolescent Pupils: A Pilot Study in Public Health Centers of Bali, Indonesia
Abstract
Introduction
Methods
Study area and design
Sample and participants
Data collection
Ethical consideration
Data analysis
Results
Discussion
Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Appendix A
| Variable | Adolescents (n=176) | Parents (n=5) | Teachers (n=8) | Health professionals (n=19) |
| Knowledge about HPV | ||||
| Do you know what HPV is? | 34.6 (28.8; 40.5) | 20.0 (-35.5; 75.5)a | 43.7 (28.9; 58.5) | 76.3 (63.9; 88.7) |
| Is HPV a virus? | 55.9 (50.2; 61.7) | 80.0 (24.5; 135.5) | 31.2 (9.6; 52.9) | 76.3 (63.9; 88.7) |
| Is HPV a sexually transmitted disease? | 54.5 (47.7; 61.3) | 80.0 (45.9; 114.0) | 37.5 (18.1; 56.8) | 71.0 (54.4; 87.7) |
| Can HPV cause cervical cancer? | 55.1 (49.6; 60.6) | 90.0 (62.2; 117.8) | 43.7 (28.9; 58.5) | 76.3 (63.9; 88.7) |
| Can HPV cause changes in the Pap (screening for cervical cancer)? | 67.0 (60.9; 73.1) | 90.0 (62.2; 117.8) | 31.2 (9.6; 52.9) | 76.3 (63.9; 88.7) |
| Is cervical cancer a major cause of cancer in women? | 51.9 (48.3; 55.6) | 60.0 (8.0; 111.9) | 25.0 (2.6; 47.3) | 78.9 (66.7; 91.2) |
| Can smoking increase the risk of cervical cancer? | 54.5 (49.1; 59.9) | 70.0 (35.9; 104.0) | 25.0 (2.6; 47.3) | 76.3 (63.9; 88.7) |
| Knowledge about HPV vaccine | ||||
| Does the HPV vaccine prevent cervical cancer? | 57.7 (53.9; 61.4) | 80.0 (45.9; 114.0) | 37.5 (18.1; 56.8) | 76.3 (63.9; 88.7) |
| Should the HPV vaccine be given before the first sexual intercourse? | 61.6 (56.4; 66.9) | 90.0 (62.2; 117.8) | 31.2 (9.6; 52.9) | 73.7 (58.9; 88.4) |
| Can the HPV vaccine be given to people who have had sex? | 58.8 (51.8; 65.8) | 80.0 (24.5; 135.5) | 37.5 (18.1; 56.8) | 76.3 (63.9; 88.7) |
| Can HPV vaccine be harmful to health? | 34.9 (28.7; 41.2) | 90.0 (62.2; 117.8) | 25.0 (2.6; 47.3) | 55.3 (31.3; 79.2) |
| Can the HPV vaccine cause HPV infection? | 56.5 (49.5; 63.5) | 90.0 (62.2; 117.8) | 12.5 (-6.8; 31.8)a | 57.9 (34.8; 80.9) |
| Is the HPV vaccine provided by the Government? | 55.9 (52.2; 59.7) | 60.0 (32.2; 87.8) | 37.5 (18.1; 56.8) | 76.3 (63.9; 88.7) |
| Is the HPV vaccine part of the girls’ immunization record? | 54.5 (50.9; 58.2) | 70.0 (14.5; 125.5) | 50.0 (27.6; 72.3) | 76.3 (63.9; 88.7) |
| Where did you hear about the HPV vaccine? | 66.5 (61.9; 71.1) | 80.0 (45.9; 114.0) | 62.5 (32.9; 92.1) | 76.3 (63.9; 88.7) |
| Are 3 doses required for complete vaccination? | 74.4 (69.3; 79.6) | 90.0 (62.2; 117.8) | 37.5 (7.9; 67.0) | 84.2 (72.7; 95.7) |
| Does the HPV vaccine lessen the chance of having genital warts? | 64.8 (58.2; 71.3) | 90.0 (62.2; 117.8) | 25.0 (2.6; 47.3) | 81.6 (69.6; 93.5) |
| Does the HPV vaccine decrease the chance of having Pap (cervical cancer screening) changes? | 63.6 (57.7; 69.5) | 90.0 (62.2; 117.8) | 50.0 (27.6; 72.3) | 68.4 (50.1; 86.7) |
| Do you think the HPV vaccine would stimulate the onset of sexual life earlier? | 56.2 (49.0; 63.5) | 80.0 (24.5; 135.5) | 18.7 (-12.3; 49.8)a | 55.3 (31.3; 79.2) |
| Do you think that after the HPV vaccine you still need to use a condom? | 53.7 (46.3; 61.0) | 80.0 (45.9; 114.0) | 37.5 (18.1; 56.8) | 73.7 (58.9; 88.4) |
| Do you think that after the HPV vaccine you still need to have the Pap (cervical cancer screening)? | 58.5 (51.5; 65.5) | 90.0 (62.2; 117.8) | 25.0 (2.6; 47.3) | 76.3 (63.9; 88.7) |
| Acceptability of HPV vaccine and female personal history | ||||
| Do you know anyone who has already had the HPV vaccine? | 44.3 (38.5; 50.1) | 20.0 (-35.5; 75.5)a | 6.2 (-8.5; 21.0)a | 71.0 (54.4; 87.7) |
| Have you taken the HPV vaccine yet? | 51.9 (48.9; 55.0) | 20.0 (-35.5; 75.5)a | 12.5 (-6.8; 31.8)a | 68.4 (50.1; 86.7) |
| Would you recommend the HPV vaccine for a child, friend, or relative to take? | 54.5 (49.3; 59.8) | 50.0 (-12.1; 112.1)a | 31.2 (9.6; 52.8) | 76.3 (63.9; 88.7) |
| Have you ever had Pap (cervical cancer screening)? | N/A | 40.0 (-11.9; 91.9)a | 12.5 (-17.0; 42.0)a | 36.8 (23.3; 50.4) |
| Have you ever had cervical cancer? | N/A | 30.0 (-25.5; 85.5)a | 12.5 (-17.0; 42.0)a | 5.3 (-5.8; 16.3)a |
| Have you ever had genital warts? | N/A | 30.0 (-25.5; 85.5)a | 25.0 (-13.7; 63.7)a | 5.3 (-5.8; 16.3)a |
| Perception of health professionals | ||||
| Patients living with HIV can take the vaccine? | N/A | N/A | N/A | N/A |
| Am I confident to indicate HPV vaccination for patients? | N/A | N/A | N/A | 55.3 (35.7; 74.8) |
| Do I feel confident giving information about HPV to patients? | N/A | N/A | N/A | 55.3 (47.7; 62.9) |
| Can pregnant women take the vaccine? | N/A | N/A | N/A | 7.9 (-1.1; 16.9)a |
| Participants | Theme | Category | Keyword |
| Health professionals | Community response | Enthusiasm | Asking questions |
| Willingness | |||
| Very good response | |||
| Vaccination requests | |||
| Demanding vaccination rights | |||
| Requesting personal information (consultation) | |||
| Information needs | Content of the vaccine | ||
| Price of the vaccine | |||
| Benefits of vaccination | |||
| Schedule of vaccination | |||
| Worries of parents due to free sex | |||
| Type of vaccine | |||
| Relation to menstruation | |||
| Expediency | Reproductive health | ||
| Prevention of diseases caused by free sex | |||
| Prevention of cervical cancer | |||
| Primary protection | |||
| Cost-effectiveness | |||
| Rejection | Vaccination caused pain for children | ||
| Children are not attending school | |||
| Halal status of vaccines | |||
| Needle phobia for children | |||
| Cervical cancer after vaccine | |||
| Child becomes sick after vaccination | |||
| Health promotion vaccine | Media | Social media (Instagram, WhatsApp, Facebook) | |
| Reproductive health counseling | |||
| Discussions at the clinic in community health centers | |||
| Immunization cards | |||
| Posyandu (Community health centers) | |||
| Time | Directly by the district health office to the health professional in community health centers | ||
| By health professionals in community health centers to school teachers | |||
| Contents | Content | ||
| Benefits | |||
| Schedule | |||
| Treatment of side effects | |||
| Target | 5th grade girls in elementary school 1st grade junior high school students | ||
| 9-13 year-old women | |||
| Public and private elementary schools | |||
| Process implementing | Informed consent | Request for approval and signature of approval | |
| program | Vaccine | Vaccination | |
| administration | Injection | ||
| Education of side effects | |||
| Follow-up | Handling side effects | ||
| Registering the next vaccine | |||
| Immunization cards | |||
| Reporting systems | |||
| Parents | Perception of vaccine | Reception | May be vaccinated |
| administration | Agree to be vaccinated | ||
| It's okay as long as it's free | |||
| May be good | |||
| Concerned and | Unclear content | ||
| worried | Understanding of benefits | ||
| Post-vaccine symptoms | |||
| Possible cervical cancer | |||
| Lack of information | Vaccine types | ||
| Vaccine benefits | |||
| Vaccine schedule | |||
| Teacher | Awareness | The importance of | Needed information, an explanation, and understanding |
| understanding | There are questions and refuse because of doubt | ||
| Risk behaviors | The content is not good from sanitary napkins | ||
| which cause HPV | How to clean up | ||
| Clean the toilet | |||
| Early free sex | |||
| Changing partners | |||
| Program sustainability | Cost reduction | Help finance and ease the burden of costs vaccine | |
| Service access | Easy to get and affordable to the community | ||
| No hassle to go to the Community health services (Puskesmas) |
References
- Palefsky, J.M. Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health. 2010, 46, S12–S19. [Google Scholar] [CrossRef] [PubMed]
- Zimet, G.D.; Rosenthal, S.L. HPV vaccine and males: issues and challenges. Gynecol Oncol. 2010, 117, S26–S31. [Google Scholar] [CrossRef] [PubMed]
- Brewer, N.T.; Fazekas, K.I. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007, 45, 107–114. [Google Scholar] [CrossRef]
- Zimet, G.D. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health. 2005, 37, S17–S23. [Google Scholar] [CrossRef]
- Gerend, M.A.; Magloire, Z.F. Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. J Adolesc Health 2008, 42, 237–242. [Google Scholar] [CrossRef]
- Ali, H.; McManus, H.; O'Connor, C.C. , et al. Human papillomavirus vaccination and genital warts in young Indigenous Australians: national sentinel surveillance data. Med J Aust. 2017, 206, 204–209. [Google Scholar] [CrossRef]
- Cartmell, K.B.; Young-Pierce, J.; McGue, S. , et al. Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action. Papillomavirus Res. 2018, 5, 21–31. [Google Scholar] [CrossRef]
- Vorsters, A.; Arbyn, M.; Baay, M. , et al. Overcoming barriers in HPV vaccination and screening programs. Papillomavirus Res. 2017, 4, 45–53. [Google Scholar] [CrossRef]
- Marlow, L.A.; Waller, J.; Wardle, J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007, 25, 1945–1952. [Google Scholar] [CrossRef] [PubMed]
- Lazcano-Ponce, E.; Rivera, L.; Arillo-Santillán, E.; Salmerón, J.; Hernández-Avila, M.; Muñoz, N. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res. 2001, 32, 243–247. [Google Scholar] [CrossRef] [PubMed]
- Endarti, D.; Satibi, S.; Kristina, S.A.; Farida, M.A.; Rahmawanti, Y.; Andriani, T. Knowledge, perception, and acceptance of HPV vaccination and screening for cervical cancer among women in Yogyakarta Province, Indonesia. Asian Pac J Cancer Prev. 2018, 19, 1105–1111. [Google Scholar] [CrossRef]
- Jaspers, L.; Budiningsih, S.; Wolterbeek, R.; Henderson, F.C.; Peters, A.A. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study. Vaccine 2011, 29, 7785–7793. [Google Scholar] [CrossRef]
- Prayudi, P.K.; Permatasari, A.A.; Winata, I.G.; Suwiyoga, K. Impact of human papilloma virus vaccination on adolescent knowledge, perception of sexual risk and need for safer sexual behaviors in Bali, Indonesia. J Obstet Gynaecol Res. 2016, 42, 1829–1838. [Google Scholar] [CrossRef] [PubMed]
- Spagnoletti, B.R.M.; Bennett, L.R.; Wahdi, A.E.; Wilopo, S.A.; Keenan, C.A. A Qualitative study of parental knowledge and perceptions of human papillomavirus and cervical cancer prevention in rural Central Java, Indonesia: understanding community readiness for prevention interventions. Asian Pac J Cancer Prev. 2019, 20, 2429–2434. [Google Scholar] [CrossRef]
- Lismidiati, W.; Emilia, O.; Widyawati, W. Need vs. financing capability: human papillomavirus vaccinations among adolescents. Asian Pac J Cancer Prev. 2019, 20, 2959–2964. [Google Scholar] [CrossRef] [PubMed]
- Sousa, P.D.; Takiuti, A.D.; Baracat, E.C.; Sorpreso, I.C.E.; de Abreu, L.C. Knowledge and acceptance of HPV vaccine among adolescents, parents and health professionals: construct development for collection and database composition. J Hum Growth Dev. 2018, 28, 58–68. [Google Scholar] [CrossRef]
- Morales-Campos, D.Y.; Markham, C.M.; Peskin, M.F.; Fernandez, M.E. Hispanic mothers' and high school girls' perceptions of cervical cancer, human papilloma virus, and the human papilloma virus vaccine. J Adolesc Health. 2013, 52, S69–S75. [Google Scholar] [CrossRef]
- Fernández, M.E.; Le, Y.C.; Fernández-Espada, N. , et al. Knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination among Puerto Rican mothers and daughters, 2010: a qualitative study. Prev Chronic Dis. 2014, 11, E212. [Google Scholar] [CrossRef] [PubMed]
- Polit, D.F.; Beck, C.T. Essentials of nursing research: appraising evidence for nursing practice. Philadelphia, USA: Wolters Kluwer Health/ Lippincott Williams & Wilkins. 2010. [Google Scholar]
- Braun, V.; Clarke, V. Using thematic analysis in psychology. Qual Res Psychol. 2006, 3, 77–101. [Google Scholar] [CrossRef]
- Batista Ferrer, H.; Audrey, S.; Trotter, C.; Hickman, M. An appraisal of theoretical approaches to examining behaviours in relation to human papillomavirus (HPV) vaccination of young women. Prev Med. 2015, 81, 122–131. [Google Scholar] [CrossRef]
- Canfell, K.; Egger, S.; Velentzis, L.S. , et al. Factors related to vaccine uptake by young adult women in the catch-up phase of the National HPV Vaccination Program in Australia: Results from an observational study. Vaccine. 2015, 33, 2387–2394. [Google Scholar] [CrossRef] [PubMed]
- Ehrenpreis, E.D.; Smith, D.G. Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic model. Papillomavirus Res. 2018, 5, 38–45. [Google Scholar] [CrossRef] [PubMed]
- Forster, A.S.; McBride, K.A.; Davies, C. , et al. Development and validation of measures to evaluate adolescents' knowledge about human papillomavirus (HPV), involvement in HPV vaccine decision-making, self-efficacy to receive the vaccine and fear and anxiety. Public Health 2017, 147, 77–83. [Google Scholar] [CrossRef]
- Gallagher, K.E.; Howard, N.; Kabakama, S. , et al. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016. Papillomavirus Res. 2017, 4, 72–78. [Google Scholar] [CrossRef] [PubMed]
| Variable | Adolescents | Parents | Teachers | Health professionals | |
| (n=176) | (n=5) | (n=8) | (n= 19) | ||
| Age (mean ±SD) | 10.3±0.5 | 35.0±6.0 | 45±15.1 | 35.8±9.2 | |
| Gender | Male | 124 (70.5) | 0 | 1 (12.5) | 0 |
| Female | 52 (29.5) | 5 (100) | 7 (87.5) | 19 (100) | |
| Ethnicity | Jawa | 18 (10.2) | 0 | 2 (10.5) | |
| Bali | 156 (88.6) | 8 (100) | 8 (100) | 16 (84.2) | |
| Kupang | 1 (0.6) | 0 | 0 | ||
| Sumba | 1 (0.6) | 0 | 0 | ||
| Batak | 0 | 0 | 0 | 1 (5.3) | |
| Religion | Islam | 21 (11.9) | 0 | 0 | 0 |
| Hindu | 152 (86.4) | 5 (100) | 8 (100) | 17 (89.5) | |
| Catholic | 1 (0.6) | 0 | 0 | 1 (5.3) | |
| Christian | 2 (1.1) | 0 | 0 | 1 (5.3) | |
| Education | Elementary school | N/A | 0 | 0 | 0 |
| Junior high school | N/A | 0 | 0 | 0 | |
| Senior high school | N/A | 8 (100) | 0 | 0 | |
| Diploma | N/A | 0 | 0 | 14 (73.7) | |
| Bachelor degree | N/A | 0 | 2 (25.0) | 4 (21.1) | |
| Master degree | N/A | 0 | 5 (62.5) | 1 (5.3) | |
| Doctor degree | N/A | 0 | 1 (12.5) | 0 | |
| Occupation | Working | N/A | 3 (60.0) | N/A | N/A |
| Not working | N/A | 2 (40.0) | N/A | N/A | |
| Family income | Less than | N/A | 1 (20.0) | N/A | N/A |
| More than | N/A | 4 (80.0) | N/A | N/A | |
| Health professional | Medical doctor | N/A | N/A | N/A | 3 (15.8) |
| Nurse | N/A | N/A | N/A | 6 (31.6) | |
| Midwife | N/A | N/A | N/A | 10 (52.6) | |
| Training regarding | Yes | N/A | N/A | N/A | 2 (10.5) |
| HPV vaccine | No | N/A | N/A | N/A | 17 (89.5) |
© GERMS 2020.
Share and Cite
Susanto, T.; Rif’ah, E.N.; Susumaningrum, L.A.; Rahmawati, I.; Yunanto, R.A.; Evayanti, N.L.P.; Utami, P.A.S. Human Papillomavirus Vaccine Acceptability Among Healthcare Workers, Parents, and Adolescent Pupils: A Pilot Study in Public Health Centers of Bali, Indonesia. GERMS 2020, 10, 184-194. https://doi.org/10.18683/germs.2020.1204
Susanto T, Rif’ah EN, Susumaningrum LA, Rahmawati I, Yunanto RA, Evayanti NLP, Utami PAS. Human Papillomavirus Vaccine Acceptability Among Healthcare Workers, Parents, and Adolescent Pupils: A Pilot Study in Public Health Centers of Bali, Indonesia. GERMS. 2020; 10(3):184-194. https://doi.org/10.18683/germs.2020.1204
Chicago/Turabian StyleSusanto, Tantut, Erwin Nur Rif’ah, Latifa Aini Susumaningrum, Ira Rahmawati, Rismawan Adi Yunanto, Ni Luh Putu Evayanti, and Putu Ayu Sani Utami. 2020. "Human Papillomavirus Vaccine Acceptability Among Healthcare Workers, Parents, and Adolescent Pupils: A Pilot Study in Public Health Centers of Bali, Indonesia" GERMS 10, no. 3: 184-194. https://doi.org/10.18683/germs.2020.1204
APA StyleSusanto, T., Rif’ah, E. N., Susumaningrum, L. A., Rahmawati, I., Yunanto, R. A., Evayanti, N. L. P., & Utami, P. A. S. (2020). Human Papillomavirus Vaccine Acceptability Among Healthcare Workers, Parents, and Adolescent Pupils: A Pilot Study in Public Health Centers of Bali, Indonesia. GERMS, 10(3), 184-194. https://doi.org/10.18683/germs.2020.1204
